Psoriasis | Janssen | C0168Z03 (PSOLAR)
Pharmaceutical Company/Sponsor:
Janssen
Code:
C0168Z03 (PSOLAR)
Title:
A Multicenter, Open Registry of Patients With Plaque Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
Type:
Observational
Phase:
4
Condition/Disease:
Psoriasis
Intervention(s)/Treatment(s):
Biological: Ustekinumab
Biological: Biological therapies other than infliximab, ustekinumab and guselkumab
Drug: Conventional systemic agents
Biological: Infliximab
Biological: Guselkumab
Status:
Recruiting
Link for Additional Information:
